|
2015 Conference Publication A Phase II Study of Everolimus in patients with FDG-PET positive intermediate grade (Ki67 3-20%) pancreatic neuroendocrine tumorMichael, M., Pavlakis, N., Wyld, D., Link, E., Liauw, W., Kuru, N. and Hicks, R. (2015). A Phase II Study of Everolimus in patients with FDG-PET positive intermediate grade (Ki67 3-20%) pancreatic neuroendocrine tumor. 12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, March 11-13, 2015. Basel, Switzerland: S. Karger AG. doi: 10.1159/000431385 |
|
2015 Journal Article Describing patterns of care in pancreatic cancer a population-based studyBurmeister, Elizabeth A., O'Connell, Dianne L., Beesley, Vanessa L., Goldstein, David, Gooden, Helen M., Janda, Monika, Jordan, Susan J., Merrett, Neil D., Payne, Madeleine E., Wyld, David and Neale, Rachel E. (2015). Describing patterns of care in pancreatic cancer a population-based study. Pancreas, 44 (8), 1259-1265. doi: 10.1097/MPA.0000000000000384 |
|
2015 Conference Publication A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302)Lawrence, Nicola, Toner, Guy, Martin, Andrew, Stockler, Martin, Yeung, Annie, Wong, Nicole, Thomson, Damien, Gebski, Val, Yip, Sonia, King, Madeleine, Friedlander, Michael, Quinn, David, Tan, Thean Hsiang, Chan, Howard, Hanning, Fritha, Weickhardt, Andrew, Jeffery, Mark, Stevanovic, Amanda, Hovey, Elizabeth, Wyld, David, Davis, Ian and Grimison, Peter (2015). A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302). COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart, Australia, 17–19 November 2015. Chichester, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12432_2 |
|
2015 Conference Publication Efficacy of PRRT in metastatic neuroendocrine tumors; a retrospective large single institutional studyJan, H., Wyld, D. and Burge, M. (2015). Efficacy of PRRT in metastatic neuroendocrine tumors; a retrospective large single institutional study. 12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona Spain, Mar 11-13, 2015. Basel, Switzerland: S. Karger AG. doi: 10.1159/000431385 |
|
2015 Conference Publication Experiences of Uncertainty and Invisibility: Women's Accounts of Living with a Rare CancerWyld, David, Gibson, Alexandra, Broom, Alex, Plage, Stefanie, Cubitt, Annette and Lwin, Zarnie (2015). Experiences of Uncertainty and Invisibility: Women's Accounts of Living with a Rare Cancer. COSA’s 42nd Annual Scientific Meeting. Rare Cancers, Hobart, TAS, Australia, 17-19 November 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12432_2 |
|
2014 Journal Article Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: a prospective analysisBeesley, Vanessa L., Green, Adele C., Wyld, David K., O'Rourke, Peter, Wockner, Leesa F., Defazio, Anna, Butow, Phyllis N., Price, Melanie A., Horwood, Keith R., Clavarino, Alexandra M. and Webb, Penelope M. (2014). Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: a prospective analysis. Obstetrical and Gynecological Survey, 69 (5), 257-259. doi: 10.1097/01.ogx.0000450117.94530.01 |
|
2014 Conference Publication Assessment of long course chemoradiotherapy (Lccrt) in regards to completion of chemotherapy. The experience of a tertiary referral hospitalChristie, Hayden, Burge, Matthew, Eastgate, Melissa and Wyld, David (2014). Assessment of long course chemoradiotherapy (Lccrt) in regards to completion of chemotherapy. The experience of a tertiary referral hospital. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, Australia, 2-4 December, 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305 |
|
2014 Conference Publication Success with Lutetium-177 DOTATATE therapy in Cushing's syndrome caused by functional pancreatic neuroendocrine tumor (pNET) with ectopic adrenocorticotropic hormone (ACTH) secretion refractory to concomitant everolimus, pasireotide and metyraponeChan, B. A., Wyld, D., Burge, M., Cuneo, R., Macfarlane, D. and Lee, K. (2014). Success with Lutetium-177 DOTATATE therapy in Cushing's syndrome caused by functional pancreatic neuroendocrine tumor (pNET) with ectopic adrenocorticotropic hormone (ACTH) secretion refractory to concomitant everolimus, pasireotide and metyrapone. 11th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona Spain, 5 - 7 March 2014. Basel, Switzerland: S. Karger AG. |
|
2014 Journal Article Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: a prospective analysisBeesley, Vanessa L., Green, Adele C., Wyld, David K., O'Rourke, Peter, Wockner, Leesa F., deFazio, Anna, Butow, Phyliss N., Price, Melanie A., Horwood, Keith R., Clavarino, Alexandra M., Australian Ovarian Cancer Study Group, Australian Ovarian Cancer Study - Quality of Life Study Investigators and Webb, Penelope M. (2014). Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: a prospective analysis. Gynecologic Oncology, 132 (1), 130-136. doi: 10.1016/j.ygyno.2013.10.004 |
|
2014 Conference Publication Time from diagnosis of rectal adenocarcinoma to commencement of long course chemoradiotherapy (Lccrt) for metropolitan versus rural patients referred to a Queensland tertiary referral hospitalChristie, Hayden, Burge, Matthew, Eastgate, Melissa and Wyld, David (2014). Time from diagnosis of rectal adenocarcinoma to commencement of long course chemoradiotherapy (Lccrt) for metropolitan versus rural patients referred to a Queensland tertiary referral hospital. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, Australia, 2-4 December, 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305 |
|
2014 Conference Publication Locally advanced and metastatic pancreatic cancer: an assessment of the provision of chemotherapy at a tertiary referral hospitalChristie, Hayden, Burge, Matthew, Eastgate, Melissa and Wyld, David (2014). Locally advanced and metastatic pancreatic cancer: an assessment of the provision of chemotherapy at a tertiary referral hospital. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, Australia, 2-4 December, 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305 |
|
2014 Conference Publication Novel succinate dehydrogenase subunit B intronic mutation in an Australian kindred with variable clinical and imaging phenotype necessitating different treatment modalities including 131-I MIBG and 177-Lutetium DOTATATELee, K., Conway, L., Burge, M., Wyld, D. and Macfarlane, D. (2014). Novel succinate dehydrogenase subunit B intronic mutation in an Australian kindred with variable clinical and imaging phenotype necessitating different treatment modalities including 131-I MIBG and 177-Lutetium DOTATATE. 11th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, 5 - 7 March 2014. Basel, Switzerland: S. Karger AG. |
|
2014 Conference Publication Rural Oncology Care Via Teleoncology and Outreach Clinics: Patient and Staff Perspectives and ComparisonsWyeth, Holly, Chan, Bryan, Burge, Matthew, Wyld, David and Eastgate, Melissa (2014). Rural Oncology Care Via Teleoncology and Outreach Clinics: Patient and Staff Perspectives and Comparisons. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, VIC Australia, 2-4 December 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305 |
|
2014 Conference Publication Assessment of time to commencement of neoadjuvant long course chemoradiotherapy (Lccrt) for locally advanced rectal adenocarcinoma patients in a tertiary referral hospitalChristie, Hayden, Burge, Matthew, Eastgate, Melissa and Wyld, David (2014). Assessment of time to commencement of neoadjuvant long course chemoradiotherapy (Lccrt) for locally advanced rectal adenocarcinoma patients in a tertiary referral hospital. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, Australia, 2-4 December, 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305 |
|
2014 Conference Publication Pathologic response of rectal adenocarcinoma to preoperative long course chemoradiotherapy (Lccrt). An assessment at a tertiary referral hospitalChristie, Hayden, Burge, Matthew, Eastgate, Melissa and Wyld, David (2014). Pathologic response of rectal adenocarcinoma to preoperative long course chemoradiotherapy (Lccrt). An assessment at a tertiary referral hospital. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, Australia, 2-4 December, 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305 |
|
2013 Journal Article The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimatesKiely, Belinda E., Martin, Andrew J., Tattersall, Martin H. N., Nowak, Anna K., Goldstein, David, Wilcken, Nicholas R. C., Wyld, David K., Abdi, Ehtesham A., Glasgow, Amanda, Beale, Philip J., Jefford, Michael, Glare, Paul A. and Stockler, Martin R. (2013). The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimates. Journal of Clinical Oncology, 31 (28), 3565-3572. doi: 10.1200/JCO.2012.44.7821 |
|
2013 Journal Article Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer - A population-based studyJordan, S., Steer, C., DeFazio, A., Quinn, M., Obermair, A., Friedlander, M., Francis, J., O'Brien, S., Goss, G., Wyld, D. and Webb, P. (2013). Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer - A population-based study. Gynecologic Oncology, 129 (2), 310-317. doi: 10.1016/j.ygyno.2013.02.007 |
|
2013 Conference Publication Pancreatic cancer patient's moderate or high unmet supportive care needs over time and risk factors of future unmet needsBeesley, Vanessa L., Janda, Monika, Wockner, Leesa F., O'Rourke, Peter, Gooden, Helen, Goldstein, David, Merrett, Neil D., Wyld, David K. and Neale, Rachel E. (2013). Pancreatic cancer patient's moderate or high unmet supportive care needs over time and risk factors of future unmet needs. COSA's 40th Annual Scientific Meeting. Cancer Care Coming of Age, Adelaide Convention Centre, Adelaide, SA Australia, 12-14 November 2013. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. |
|
2012 Conference Publication Pulmonary Embolism in Medical Oncology Patients: Symptomatic Versus IncidentalThaker, D. A., Blazak, J., Wyld, D., Steinke, K., Hughes, B. and Burge, M. (2012). Pulmonary Embolism in Medical Oncology Patients: Symptomatic Versus Incidental. HOBOKEN: WILEY-BLACKWELL. |
|
2012 Journal Article Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trialNeoptolemos, John P., Moore, Malcolm J., Cox, Trevor F., Valle, Juan W., Palmer, Daniel H., McDonald, Alexander C., Carter, Ross, Tebbutt, Niall C., Dervenis, Christos, Smith, David, Glimelius, Bengt, Charnley, Richard M., Lacaine, François, Scarfe, Andrew G., Middleton, Mark R., Anthoney, Alan, Ghaneh, Paula, Halloran, Christopher M., Lerch, Markus M., Oláh, Attila, Rawcliffe, Charlotte L., Verbeke, Caroline S., Campbell, Fiona, Büchler, Markus W., European Study Group for Pancreatic Cancer and Wyld, David (2012). Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA, 308 (2), 147-56. doi: 10.1001/jama.2012.7352 |
